Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss

v3.19.3
Condensed Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues:        
Collaboration revenue $ 3,376 $ 7,666 $ 21,191 $ 26,177
Total revenues 3,376 7,666 21,191 26,177
Operating expenses:        
Research and development 4,746 9,664 22,694 32,482
General and administrative 2,013 2,660 7,658 7,967
Total operating expenses 6,759 12,324 30,352 40,449
Loss from operations (3,383) (4,658) (9,161) (14,272)
Other income (expense):        
Interest income 119 253 491 730
Interest expense 0 (189) 0 (561)
Other income (expense) 11 5 14 (1)
Total other income 130 69 505 168
Net loss (3,253) (4,589) (8,656) (14,104)
Other comprehensive income (loss):        
Net unrealized gains (losses) on marketable securities (4) 29 18 65
Comprehensive loss $ (3,257) $ (4,560) $ (8,638) $ (14,039)
Net loss per share, basic and diluted $ (0.10) $ (0.15) $ (0.26) $ (0.47)
Weighted average shares outstanding used in computing net loss per share, basic and diluted 33,170 30,190 33,168 30,118